Ontology highlight
ABSTRACT:
PROVIDER: PRJNA1237397 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR32742629_1.fastq.gz | Fastqsanger.gz | |||
| SRR32742629_2.fastq.gz | Fastqsanger.gz | |||
| SRR32742630_1.fastq.gz | Fastqsanger.gz | |||
| SRR32742630_2.fastq.gz | Fastqsanger.gz | |||
| SRR32742631_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 58 |
Similar Datasets
Project description:Natural products represent a rich source for antibiotics addressing versatile cellular targets. The deconvolution of their targets via chemical proteomics is often challenged by the introduction of large photocrosslinkers. Here we select elegaphenone, a largely uncharacterized natural product antibiotic bearing a native benzophenone core scaffold, for affinity-based protein profiling (AfBPP) in Gram-positive and Gram-negative bacteria. This study utilizes the alkynylated natural product scaffold as a probe to uncover intriguing biological interactions with the transcriptional regulator AlgP. Furthermore, proteome profiling of a Pseudomonas aeruginosa AlgP transposon mutant revealed unique insights into the mode of action. Elegaphenone enhanced the killing of intracellular P. aeruginosa in macrophages exposed to sub-inhibitory concentrations of the fluoroquinolone antibiotic norfloxacin.
2021-09-08 | PXD010476 | Pride
Project description:Praziquantel mode of action and resistance
| PRJEB1281 | ENA
Project description:Here, we examined the liver microRNA profile of male Fischer rats exposed through their diet to genotoxic (2-acetylaminofluorene) and epigenetic (phenobarbital, diethylhexylphthalate, methapyrilene HCL, monuron, and chlorendic acid) chemical hepatocarcinogens, as well as to non-hepatocarcinogenic treatments (benzophenone, and diethylthiourea) for three months. The aim of the study was to investigate how liver miRNA profiles relate to mode of action and carcinogenic potential of chemicals.
2013-07-03 | GSE48492 | GEO
Project description:Chemical proteomics encompasses novel drug target deconvolution methods in which compound modification is not required. Herein we use Thermal Proteome Profiling, Functional Identification of Target by Expression Proteomics and multiplexed redox proteomics for deconvolution of auranofin targets to aid elucidation of its mechanisms of action. Auranofin (Ridaura®) was approved for treatment of rheumatoid arthritis in 1985. Because several clinical trials are currently ongoing to repurpose auranofin for cancer therapy, comprehensive characterization of its targets and effects in cancer cells is important. Together, our chemical proteomics tools confirmed thioredoxin reductase 1 (TXNRD1) as a main auranofin target, with perturbation of oxidoreductase pathways as the top mechanism of drug action. Additional indirect targets included NFKB2 and CHORDC1. Our comprehensive data can be used as a proteomic signature resource for further analyses of the effects of auranofin. Here we also assessed the orthogonality and complementarity of different chemical proteomics methods that can furnish invaluable mechanistic information and thus the approach can facilitate drug discovery efforts in general.
2020-03-19 | PXD016776 | Pride
Project description:Transcriptomics and metabolomics provide useful data to identify the mode of action for chemical-induced murine liver tumors and to exclude alternative modes of action. This data was incorporated into a mode of action assessment, for the murine liver hepatocellular carcinomas associated with 80-week dietary exposure to CD-1 mice of the novel complex II succinate dehydrogenase inhibitor (SDHI), cyclobutrifluram. The assessment was conducted using the framework developed by the International Programme on Chemical Safety (IPCS) and the International Life Science Institute (ILSI), based on activation of the constitutive androstane receptor (CAR) and subsequent downstream events. Cyclobutrifluram activated human and mouse CAR in an in vitro transactivation assay. Dietary administration of cyclobutrifluram was associated with time and/or dose-dependent liver weight increases, minimal to moderate hepatic centrilobular hypertrophy, induction of CAR-related enzyme activity, specifically CYP2B and CYP3A, and hepatocellular proliferation. Transcriptomic assessment of the liver identified gene expression profiles consistent with CAR activation. Metabolomic assessment indicated that cyclobutrifluram induced similar biochemical changes to the known CAR activator phenobarbital. Alternative hypotheses to CAR-induced hepatic tumors were assessed and considered to be non-relevant. The transcriptomic and particularly the metabolomic assessments indicated that cyclobutrifluram did not have activity other than that related to CAR induction.
2025-12-31 | GSE289533 | GEO
Project description:This SuperSeries is composed of the following subset Series: GSE21008: Linking toxicant physiological mode of action with induced gene expression changes in Caenorhabditis elegans: atrazine GSE21010: Linking toxicant physiological mode of action with induced gene expression changes in Caenorhabditis elegans: cadmium GSE21011: Linking toxicant physiological mode of action with induced gene expression changes in Caenorhabditis elegans: fluoranthene Refer to individual Series
2010-03-23 | E-GEOD-21012 | biostudies-arrayexpress
Project description:Thiolutin is a well-known and long-used natural product transcription inhibitor with an unresolved mode of action. Recent studies have identified Zn2+-chelation activity for both thiolutin and the related dithiolopyrrolone holomycin, with direct inhibition of RNA polymerases ruled out as a mode of action. However, negative results for direct transcription inhibition of RNA polymerases in recent studies are contradicted by previously observed thiolutin inhibition of extract fractions containing yeast RNA Polymerases I, II, and III. Here, we present chemical genetic and biochemical approaches to investigate the mode of action of thiolutin. We identify diverse classes of mutant that alter sensitivity to thiolutin. We functionally dissect the multidrug resistance and thioredoxin pathways controlling thiolutin sensitivity. We provide genetic evidence that thiolutin causes oxidation of thioredoxins in vivo and suggest that thiolutin both induces oxidative stress and alters Zn2+, Cu2+ and Mn2+ homeostasis in vivo, recapitulating previously observed thiolutin interactions with Zn2+. Finally, our results resolve contradictory biochemical results for thiolutin inhibition of transcription by direct demonstration of thiolutin inhibition of RNA polymerase II (Pol II) in vitro. Inhibitory activity requires both appropriate reduction of thiolutin and the presence of Mn2+. Thio/Mn2+ inhibition is abrogated when template DNA is pre-bound to Pol II or when excess DTT is present, and renders Pol II pause prone in elongation if initiation is bypassed using a pre-formed Pol II elongation complex. Together, we propose that thiolutin directly inhibits Pol II transcription through a novel mechanism distinct from known transcription inhibitors.
2025-10-31 | GSE248157 | GEO
Project description:Early identification of a compound’s mode of action can greatly benefit the discovery process. Thermal proteomics profiling (TPP) is a powerful, unbiased tool that can be used to identify potential ligands of protein targets. TPP takes advantage of the fact that a ligand binding to its target protein can significantly stabilise that protein, increasing its melting temperature (Tm). We previously optimised this technique for use in drug target deconvolution in the kinetoplastid parasite, Leishmania donovani1 and here report the optimisation and validation of TPP in the malaria-causing parasite P. falciparum.
2022-10-13 | PXD025182 | Pride